January 29, 2010 — Women who are at risk of lower-leg amputation fare even better than men when they have minimally invasive treatment to open up the blocked arteries causing the problem, suggest results of a study presented at the 22nd annual International Symposium on Endovascular Therapy (ISET) earlier this month.
Jan. 25, 2010 — The first commercial implants of the ATS 3f Enable Aortic Bioprosthesis were recently performed at the University of Berne Hospital, Berne, Switzerland by Lars Englberger, M.D., Mario Stalder, M.D., and professor Thierry Carrel. The procedures were completed using a sutureless technique and the patients are recovering with no complications.
January 26, 2010 — According to data appearing today in JAMA , patients with atrial fibrillation, a common heart rhythm disorder, who were treated with catheter ablation using the NaviStar ThermoCool Catheter demonstrated significantly better outcomes at one year compared to those receiving drug therapy.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 28, 2010 – Minimally invasively emergency repair of ruptured abdominal aortic aneurysms (AAA) using stent grafts could save more lives in some cases than traditional open surgery, new data suggests. The latest research on AAA was presented at the 22nd annual International Symposium on Endovascular Therapy (ISET).
January 27, 2010 – Robust blood pressure measurements via fiberoptic sensors will be added to the Abiomed Impella percutaneous ventricular assist device (P-VAD).
January 27, 2010 – New 6, 7 and 8 mm diameters of the Maris Plus self-expanding peripheral stent system, were launched today in Europe for interventions involving the superficial femoral arteries (SFA). The 9, 10 and 12mm diameters of the stent are already marketed for the iliac artery.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 27, 2010 – A German study enrolled its first 20 patients to investigate the utility of muscular counter pulsation (MCP) in patients with early-stage heart failure.
Several vendors explained recent trends in cardiac PACS during the Radiological Society of North America (RSNA) annual meeting Nov. 29 – Dec. 3 in Chicago. Industry experts from Siemens, Infinitt, McKesson, Agfa, Visage, Thinking Systems, Brit, Fuji/ProSolv, Carestream, and ScImage all agreed on the following points: More Than Pictures
January 26, 2010 – Surgical ventricular assist device (VAD) maker Thoratec Corp. acquired a catheter-based pump technology and plans to develop a minimally invasive, axial flow pump that can be delivered percutaneously in the cardiac catheterization lab.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE Hitachi Nuclear Energy (GEH) to help develop a U.S. supply of a radioisotope used in more than 20 million annual, domestic diagnostic medical procedures.
January 25, 2010 – Expanding its peripheral vascular disease product offerings, Medtronic Inc. today signed an agreement to acquire Invatec and two affiliated companies.
January 25, 2010 - In a significant development in treating congenital heart disease, the Medtronic Melody Transcatheter Pulmonary Valve today became the first transcatheter valve approved for use by the FDA.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 25, 2010 - With more than 3,000 requests for medical devices to get 510(k) clearance each year, the U.S. Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a comprehensive study of the process, which is not scheduled to be concluded for another year.
January 25, 2010 - Heart failure is a serious medical condition, in which the heart muscle progressively loses its ability to pump blood, that affects more than five million people in the United States and results in about 1.1 million hospitalizations and 300,000 deaths each year.
January 25, 2010 – First-in-man procedures and a feasibility study in Europe were recently initiated for a new minimally invasive aortic valve surgery system.